ANTI-CANCER ACTIVITY OF GRAVIOLA (ANNONA MURICATA) LEAVES EXTRACT ON INDUCED BREAST CANCER IN RATS’ MODEL
Keywords:breast cancer, graviola, phytochemical, DMBA, 5-Flurouracil, P53, Bcl2
Breast cancer is the most frequent type of invasive cancer in women. However, chemotherapy affects all cells that grow and divide quickly in the body, including cancer and normal cells. On the other hand, Graviola is commonly used as a source of food and has a wide range of bioactive components. In this study, out of 50 albino rats, breast cancer was induced in 40 rats using 7,12-dimethylbenanthracene (DMBA). These rats were subjected to the treatment using Graviola leaves ethanolic extract (GLEE) and 5-Fluorouracil (5-FU) to evaluate the anti-carcinogenic activity and the immunohistochemical changes. A single oral dose of DMBA led to the induction of rats’ breast cancer. Induced mammary tumors were diagnosed, and all were malignant without any benign tumor. Among the malignant tumors, non-invasive, invasive, mixed (invasive and non-invasive), and unclassified malignant tumors were detected. The immunohistochemical analysis showed that estrogen and progesterone receptors revealed negative nuclear expression. However, HER2 receptors score was +3, and Ki-67 revealed 85-90% nuclear stainability, denoting a very high proliferative index. The morphometric analysis revealed that staining reactivities of HER2 and Ki-67 were 60.66 and 89.84%, respectively, and were significantly higher than ER (15.24 %) and PR (15.68%). Genetic studies revealed marked upregulation of P53 with GLEE more than 5-FU while Bcl2 showed down regulation with GLEE more than 5-FU. The quantitative analysis of GLEE phytochemical constituents showed the presence of some bioactive chemical compounds that exhibit many therapeutic activities. Therefore, GLEE improved histological appearance of DMBA induced breast cancer in female rats. Therefore, GLEE could be a promising natural alternative to chemotherapy agents as a potent anticancer.
● 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Inter J Cancer 2014; 136: E359-E386. https://doi.org/10.1002/ijc.29210.
● 2. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA: Cancer J Clin 2010; 60 (5): 277–300. https://doi.org/10.3322/caac.20073.
● 3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: Cancer J Clin 2020; 70 (1): 7–30. https://doi.org/10.3322/caac.21590.
● 4. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F. Breast cancer. Nat Rev Dis Primers 2019; 5 (1). https://doi.org/10.1038/s41572-019-0111-2.
● 5. Masood S. Prognostic/Predictive Factors in Breast Cancer. Clin Lab Med 2005; 25 (4): 809–25. https://doi.org/10.1016/j.cll.2005.08.012.
● 6. Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Inter J Mol Sci 2017; 18 (12): 2589. https://doi.org/10.3390/ijms18122589.
● 7. El-Beltagy AEFBM, Elsyyad HIH, Abdelaziz KK, Madany AS, Elghazaly MM. Therapeutic Role of Annona muricata Fruit and Bee Venom Against MNU-Induced Breast Cancer in Pregnant Rats and its Complications on the Ovaries. Breast Cancer 2021; 13: 431–445. https://doi.org/10.2147/BCTT.S306971.
● 8. Gnanga MNG, Assanhou AG, Ganfon H, Agbokponto EJ, Gbaguidi FA, Ahyi V. Annona muricata L. and Annona squamosa L. (Annonaceae): A review of their traditional uses and anti-cancer activities. J Pharm Phytochem 2021; 10 (1): 40–1. https://doi.org/10.22271/phyto.2021.v10.i1a.13287.
● 9. Sun S, Liu J, Zhou N, Zhu W, Dou QP, Zhou K. Isolation of three new annonaceous acetogenins from Graviola fruit (Annona muricata) and their anti-proliferation on human prostate cancer cell PC-3. Bioorg Med Chem Lett 2016; 26 (17): 4382-–5. https://doi.org/10.1016/j.bmcl.2015.06.038
● 10. Kossouoh C, Moudachirou M, Adjakidje V, Chalchat JC, Figuérédo G. Essential Oil Chemical Composition of Annona muricata L. Leaves from Benin. J Essential Oil Res 2007; 19 (4): 307–9. https://doi.org/10.1080/10412905.2007.9699288
● 11. Nawwar M, Ayoub N, Hussein S, Hashim A, El-Sharawy R, Wende K, Harms M, Lindequist U. Flavonol triglycoside and investigation of the antioxidant and cell stimulating activities of Annona muricata Linn. Arch Pharm Res 2012; 35 (5): 761–7. https://doi.org/10.1007/s12272-012-0501-4.
● 12. Jiménez VM, Gruschwitz M, Schweiggert RM, Carle R, Esquivel P. Identification of phenolic compounds in soursop (Annona muricata) pulp by high-performance liquid chromatography with diode array and electrospray ionization mass spectrometric detection. Food Res Inter 2014; 65: 42–6. https://doi.org/10.1016/j.foodres.2014.05.051.
● 13. Yang C, Gundala SR, Mukkavilli R, Vangala S, Reid MD, Aneja R. Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer. Carcinogenesis 2015; 36 (6): 656–65. https://doi.org/10.1093/carcin/bgv046
● 14. George VC, Kumar DRN, Rajkumar V, Suresh PK, Kumar RA. Quantitative Assessment of the Relative Antineoplastic Potential of the n-butanolic Leaf Extract of Annona Muricata Linn. in Normal and immortalized Human Cell Lines. Asian Pacific J Cancer Prev 2012; 13 (2): 699–704. https://doi.org/10.7314/apjcp.2012.13.2.699.
● 15. Moghadamtousi ZS, Karimian H, Rouhollahi E, Paydar M, Fadaeinasab M, Abdul Kadir H. Annona muricata leaves induce G1 cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells. J Ethnopharmacol 2014; 156: 277–89. https://doi.org/10.1016/j.jep.2014.08.011.
● 16. Moghadamtousi ZS, Rouhollahi E, Karimian H, Fadaeinasab M, Firoozinia M, Ameen Abdulla M, Abdul Kadir H. The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach. PloS One 2015; 10 (4): e0122288–. https://doi.org/10.1371/journal.pone.0122288.
● 17. Rady I, Bloch MB, Chamcheu RCN, Banang Mbeumi S, Anwar MR, Mohamed H, Babatunde AS, Kuiate JR, Noubissi FK, El Sayed KA, Whitfield GK, Chamcheu JC. Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review. Oxid Med Cellular Long 2018; 2018: 1826170. https://doi.org/10.1155/2018/1826170.
● 18. Prince GT, Cameron MC, Fathi R, Alkousakis T (2018). Topical 5-fluorouracil in dermatologic disease. Inter J Dermatol 2018; 57 (10): 1259–64. https://doi.org/10.1111/ijd.14106.
● 19. Barnes DM, Camplejohn RS. P53, apoptosis, and breast cancer Review. J Mammary Gland Biol Neoplasia 1996; 1 (2): 163-75. doi: 10.1007/BF02013640.
● 20. Zimmermann KC, Green DR. How cells die: apoptosis pathways, J Allergy Clin Immunol 2001; 108: S99-S103.
● 21. Tiwari AK, Saha SN, Yadav VP, et al. Extraction and characterization of pectin from orange peels. Inter J Biotechnol Biochem 2017; 13 (1): 39–47.
● 22. Foong CP, Hamid RA. Evaluation of anti-inflammatory activities of ethanolic extract of Annona muricata leaves. Revista Brasileira de Farmacognosia. 2012; 22: 1301–7.
● 23. Yang H, Huang S, Wei Y, Cao S, Pi C, Feng T, Liang J, Zhao L, Ren G. Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways. Journal of Cancer 2017; 8 (18): 3697–706.
● 24. Bancroft JD, Suvarna SK, Layton C, Bancroft JD, Suvarna SK, Layton C. Acknowledgments. In Bancroft’s Theory and Practice of Histological Techniques 2019; (pp. ix–x). Elsevier. https://doi.org/10.1016/b978-0-7020-6864-5.04001-9.
● 25. Hammond MEH, Hayes DF, Wolff AC, Mangu PB, Temin S. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 2010; 6 (4): 195–7. https://doi.org/10.1200/JOP.777003.
● 26. Joensuu K, Leidenius M, Kero M, Andersson LC, Horwitz KB, Heikkilä P. ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer-Reduced CK5 Expression in Metastases. Breast Cancer: Basic Clin Res 2013; 7: 23–4. https://doi.org/10.4137/BCBCR.S10701
● 27. Cheang MCU, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J National Cancer Inst 2009; 101 (10): 736–50. https://doi.org/10.1093/jnci/djp082.
● 28. Urruticoechea A, Smith IE, Dowsett M. (2005). Proliferation Marker Ki-67 in Early Breast Cancer. J Clin Oncol 2005; 23 (28): 7212–20. https://doi.org/10.1200/jco.2005.07.501
● 29. Cui W, Guo H, Cui H (2015). Vanadium toxicity in the thymic development. Oncotarget 2015; 6 (30): 28661-28677. https://doi.org/10.18632/oncotarget.5798.
● 30. Bhatia R, Rawal RK. Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer. Mini Rev Med Chem 2019; 19 (17):1443–58
● 31. Feng M, Feng C, Yu Z, Fu Q, Ma Z, Wang F, Wang F, Yu L. Histopathological Alterations During Breast Carcinogenesis in a Rat Model Induced by 7,12-Dimethylbenz (a) Anthracene and EstrogenProgestogen Combinations. Int J Clin Exp Med 2015; 8 (1): 346–57.
● 32. Weil S, Kito K, Miyoshi A, Matsumoto S, Kauzi A, Aramoto T, Abe Y, Ueda N. Incidence of p53 and ras gene mutations in DMBA-induced rat Leukemias. J Exper Clin Cancer Res 2002; 3 (21): 1756–66.
● 33. Ma Z, Kim YM, Howard EW, Feng X, Kosanke SD, Yang S, Jiang Y, Parris AB, Cao X, Li S, Yang X. DMBA Promotes Erbb2mediated Carcinogenesis Via Erbb2 and Estrogen Receptor Pathway Activation and Genomic Instability. Oncol Rep 2018; 40 (3): 1632-–40.
● 34. Bishayee A, Mandal A, Thoppil RJ, Darvesh AS, Bhatia D. Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer. Inter J Cancer 2013; 133 (5): 1054–63. https://doi.org/10.1002/ijc.28108.
● 35. Alessandra-Perini J, Perini JA, Rodrigues-Baptista KC, de Moura RS, Junior AP, Dos Santos TA, Souza PJC, Nasciutti LE, Machado DE. Euterpe oleracea extract inhibits tumorigenesis effect of the chemical carcinogen DMBA in breast experimental cancer. BMC Comp Altern Med 2018; 18 (1): 116. https://doi.org/10.1186/s12906-018-2183-z
● 36. Deepalakshmi K, Mirunalini S. Modulatory effect of Ganoderma lucidum on expression of xenobiotic enzymes, oxidant-antioxidant and hormonal status in 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. Pharm Magaz 2013; 9 (34): 167–75. https://doi.org/10.4103/0973-1296.111286.
● 37. Nishimura R, Osako T, Okumura Y, Hayashi M, Toyozumi Y, Arima N. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Therap Med 2010; 1 (5): 747–54. https://doi.org/10.3892/etm.2010.133
● 38. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ. Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer. JNCI J Nation Cancer Inst 2003; 95 (2): 142–53. https://doi.org/10.1093/jnci/95.2.142.
● 39. Ojezele OJ, Ojezele MO, Adeosun AM. Comparative phytochemistry and antioxidant activities of water and ethanol extract of Annona muricata Linn Leaf, seed and fruit. Adv Biol Res 2016; 10 (4): 230–5. https://doi.org/10.5829/idosi.abr.2016.10.4.10514.
● 40. Magadi VP, Ravi V, Arpitha A, Litha Kumaraswamy K, Manjunath K. (2015). Evaluation of cytotoxicity of aqueous extract of Graviola leaves on squamous cell carcinoma cell-25 cell lines by 3-(4,5-dimethylthiazol-2-Yl) -2,5-diphenyltetrazolium bromide assay and determination of percentage of cell inhibition at G2M phase of cell c. Contemporary Clin Dent 2015; 6 (4): 529–33. https://doi.org/10.4103/0976-237X.169863.
● 41. de Pedro N, Cautain B, Melguizo A, Vicente F, Genilloud O, Peláez F, Tormo JR. (2012). Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway. J Bioenerg Biomem 2012; 45: 153–64. https://doi.org/10.1007/s10863-012-9489-1.
● 42. Jeong SH. Inhibitory effect of Phytol on cellular senescence. Biomed Dermatol 2018; 2: 13. https://doi.org/10.1186/s41702-018-0025-8.
● 43. Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett 2012; 323: 29–40.
● 44. Dai Y, Hogan S, Schmelz EM, Ju YH, Canning C, Zhou K. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregu-lation of EGFR expression. Nutr Cancer 2011; 63: 795–801.
● 45. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87: 99–163.
● 46. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discovery Med 2010; 9: 145–52.
How to Cite
Copyright (c) 2023 SLOVENIAN VETERINARY RESEARCH
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.